Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Gastroenterology

Journal Scan / Research · April 06, 2023

Budesonide vs Prednisone as a First-Line Treatment in Patients With Autoimmune Hepatitis

Hepatology (Baltimore, Md.)

 

Additional Info

Hepatology (Baltimore, Md.)
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration
Hepatology 2023 Apr 01;77(4)1095-1105, Á Díaz-González, M Hernández-Guerra, I Pérez-Medrano, V Sapena, M Riveiro-Barciela, A Barreira-Díaz, E Gómez, RM Morillas, M Del Barrio, L Escudé, B Mateos, D Horta, J Gómez, I Conde, C Ferre-Aracil, I El Hajra, A Arencibía, J Zamora, A Fernández, M Salcedo, E Molina, A Soria, P Estévez, C López, C Álvarez-Navascúes, M García-Retortillo, J Crespo, MC Londoño

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading